Pactiv Evergreen INC

Pactiv Evergreen Inc. has been acquired by Novolex Holdings, LLC in a merger transaction completed on April 1, 2025, resulting in Pactiv Evergreen becoming a wholly-owned subsidiary of Novolex.

Pactiv Evergreen Inc. announces it has received all required regulatory approvals for its acquisition by Novolex, with the transaction expected to close on April 1, 2025.

Pactiv Evergreen Inc. announced the conditional redemption of its senior secured notes due 2027 and 2028, while Novolex Holdings, LLC launched a tender offer for Pactiv LLC's debentures, both contingent on the consummation of the previously announced merger between Pactiv Evergreen and Novolex.

Pactiv Evergreen's acquisition by Novolex is progressing as the Hart-Scott-Rodino waiting period has expired, moving the deal closer to completion.

Pactiv Evergreen Inc. has agreed to be acquired by Novolex for $18.00 per share in an all-cash transaction valued at $6.7 billion, including debt.

Pactiv Evergreen's third quarter results show a net loss due to a significant impairment charge from a mill divestiture, despite improved adjusted EPS and EBITDA compared to the previous quarter.

Pactiv Evergreen's Q3 2024 results were significantly impacted by restructuring charges and a challenging demand environment, leading to a net loss.

Pactiv Evergreen Inc. saw a significant improvement in net income for the second quarter of 2024, despite a decrease in overall revenue compared to the same period last year.

Pactiv Evergreen Inc. saw a return to profitability in the first quarter of 2024, driven by increased gross profit and reduced restructuring charges, despite a decrease in net revenues.

Pactiv Evergreen Inc. files an amendment to its annual report to include information required by Part III of Form 10-K, related to directors, executive officers, compensation, and related matters, due to the pending merger with Novolex Holdings, LLC.

Pactiv Evergreen Inc. reports a net loss for 2024 amidst a pending merger with Novolex, impacting financial performance and future outlook.

Pactiv Evergreen's 10-K filing details a year of restructuring, including segment consolidation and facility closures, alongside strategic initiatives focused on growth and sustainability.

Packaging Finance Ltd, a 10% owner of Pactiv Evergreen Inc., disposed of its shares following a merger agreement where each share was converted into $18.00 in cash.

Director Allen Hugli reports the disposal of Pactiv Evergreen shares due to a merger agreement, where shares were converted to cash.

Following the merger of Pactiv Evergreen Inc. with a subsidiary of Novolex Holdings, LLC, executive Wulf Eric reports adjustments to his holdings of common stock and restricted stock units (RSUs) due to the merger agreement.

Douglas Owenby, Chief Operations Officer of Pactiv Evergreen Inc., reports the disposition of shares due to the merger with Novolex Holdings, LLC.

Chandra J. Mitchell, Chief Legal Officer & Secretary of Pactiv Evergreen Inc., reports the disposition of shares due to a merger, converting stock and unvested RSUs into cash.

Tim A. Levenda, President of Foodservice at Pactiv Evergreen, reports the acquisition and disposal of common stock and derivative securities due to the merger with Novolex Holdings, LLC.

Pactiv Evergreen Inc. is set to be acquired by Novolex Holdings, LLC, in an all-cash merger transaction where shareholders will receive $18 per share.

Pactiv Evergreen Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.

Pactiv Evergreen's 2024 annual meeting will address director elections, auditor ratification, executive compensation, equity incentive plan amendments, and officer exculpation.